Treatment patterns, clinical outcomes, health resource utilization, and cost in patients with BRCA-mutated metastatic breast cancer treated in community oncology settings.

Affiliation

Vector Oncology, 6555 Quince, Suite 400, Memphis, TN 38119, United States. Electronic address: [Email]

Abstract

This retrospective study of community oncology patients with breast cancer gene (BRCA)-mutated metastatic breast cancer (MBC) examined treatment outcomes and health resource utilization (HRU) and costs for a sample of patients with human epidermal growth factor receptor 2 (HER2)-negative disease who were either hormone receptor positive (HR+) or triple negative breast cancer (TNBC).

Keywords

BRCA-mutated breast cancer,Clinical outcomes,Cost,Health resource utilization,Treatment patterns,

OUR Recent Articles